clinical trial · NCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
UMC Utrecht·—·recruiting·n = 1,200
Atopic Dermatitis
brief summary
The BioDay Registry aims to address the need for daily practice data regarding the effectiveness and safety of new systemic treatment options (like biologics and Janus kinase inhibitors) in patients with atopic dermatitis and effect on other atopic comorbidities in a multicenter setting. The registry already consists of several additional modules concerning atopic comorbidities, like food allergy and asthma, and a module for conjunctivitis during biologic treatment.
started
Jan 1, 2018
primary completion
Dec 31, 2028
completion
Dec 31, 2028
last updated
Mar 28, 2025
official title
BioDay Registry: Prospective, Observational Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Diseases in Daily Practice
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol